Lucentis Versus Mitomycin C During Glaucoma Surgery
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
Does a new add on (or adjunctive) therapy used in glaucoma surgery improve the success of
trabeculectomy? Ranibizumab may offer benefit similar to mitomycin C in preventing
epi-scleral fibrosis while avoiding the well known complications of mytomycin C which include
late bleb leaks, hypotony and infection.